A New York man recently filed a claim against Janssen Pharmacetuicals, alleging he suffered an acute gastrointestinal bleed caused by Xarelto.

According to the Xarelto lawsuit, the plaintiff, Gary S., took Xarelto for a period of several months, from April 15, 2016 to Aug. 8, 2016. Gary was prescribed Xarelto in order to treat atrial fibrillation.

The reason Gary stopped taking Xarelto just a few months later? He was admitted to the hospital after suffering an acute gastrointestinal bleed caused by Xarelto. He remained in the hospital for several days, and his doctors ordered him to stop taking Xarelto.

Xarelto Background

Xarelto (rivaroxaban) is manufactured by Janssen, a prominent subsidiary of pharmaceutical giant Johnson & Johnson. Xarelto entered the U.S. market on July 1, 2011, and is one of a class of drugs known as New Oral Anticoagulants (“NOACs”). These drugs are approved to reduce the risk of stroke and systemic embolism by preventing blood clotting.

Other NOACs include popular anticoagulants Pradaxa and Eliquis. Collectively, these are some of the most popular anticoagulants available on the market.

However, despite the popularity of Xarelto, a growing number of Xarelto lawsuits like this one are being filed over serious complications, like in the case of this plaintiff’s acute gastrointestinal bleed caused by Xarelto. Plaintiffs allege that Janssen knew about the Xarelto internal bleeding linked with the drug, and yet failed to adequately warn both consumers and the medical community about these Xarelto risks.

While Xarelto is used to prevent often dangerous blood clots, clots can in emergency bleeding situations be a body’s only available life-saving function.

In extreme situations like a serious accident, emergency surgery, or internal bleeding, the body forms blood clots in order to slow bleeding. Patients taking blood thinners like Xarelto, however, may be unable to form these life-saving clots in these kinds of situations, and may suffer from Xarelto side effects as a result.

Xarelto complications, including internal bleeding, can lead to permanent injury or even death.

After suffering from this acute gastrointestinal bleed caused by Xarelto, Gary decided to respond by filing a Xarelto lawsuit against Janssen.

The action was filed on multiple counts, including strict liability, manufacturing defect, design defect, failure to warn, negligence, breach of express and implied warranties, negligent misrepresentation, and fraud.

Filing a Xarelto Lawsuit

If you or someone you love has suffered from complications like an acute gastrointestinal bleed caused by Xarelto, or even death caused by Xarelto, you may be able to file a Xarelto lawsuit.

While filing a lawsuit cannot reverse the pain and suffering of internal bleeding and other Xarelto complications, it can help to compensate for the financial losses from medical expenses and lost wages.

The Xarelto Lawsuit is Case No. 2:17-cv-04589-EEF-MBN, in the U.S District Court for the Eastern District of Louisiana.